These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7943168)

  • 21. Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses: association with intrathymic pathogenesis of myasthenia gravis.
    Hara H; Hayashi K; Ohta K; Itoh N; Ohta M
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1269-75. PubMed ID: 8352784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis.
    Geuder KI; Marx A; Witzemann V; Schalke B; Toyka K; Kirchner T; Müller-Hermelink HK
    Dev Immunol; 1992; 2(2):69-75. PubMed ID: 1643420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central role of interferon-beta in thymic events leading to myasthenia gravis.
    Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymic remodeling associated with hyperplasia in myasthenia gravis.
    Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
    Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia.
    Berrih-Aknin S; Ruhlmann N; Bismuth J; Cizeron-Clairac G; Zelman E; Shachar I; Dartevelle P; de Rosbo NK; Le Panse R
    Ann Neurol; 2009 Oct; 66(4):521-31. PubMed ID: 19847900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic changes of the subseptal thymic epithelium in myasthenia gravis.
    Savino W; Takacs L; Monostori E; Dardenne M
    Thymus; 1988-1989; 12(2):111-6. PubMed ID: 2471300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice.
    Schols D; Vandekerckhove B; Jones D; Roncarolo MG
    J Immunol; 1994 Mar; 152(5):2198-206. PubMed ID: 8133034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis.
    Wakkach A; Guyon T; Bruand C; Tzartos S; Cohen-Kaminsky S; Berrih-Aknin S
    J Immunol; 1996 Oct; 157(8):3752-60. PubMed ID: 8871679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.
    Schoser B; Jacob S; Hilton-Jones D; Müller-Felber W; Kubisch C; Claus D; Goebel HH; Vita G; Vincent A; Toscano A; Van den Bergh P
    Neuromuscul Disord; 2009 Mar; 19(3):223-8. PubMed ID: 19208478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
    Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
    Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
    Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
    Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ.
    Weiss JM; Cufi P; Le Panse R; Berrih-Aknin S
    Rev Neurol (Paris); 2013; 169(8-9):640-9. PubMed ID: 24008049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized thymic Langerhans' cell histiocytosis and its relationship with myasthenia gravis. Immunohistochemical, ultrastructural, and cytometric studies.
    Gilcrease MZ; Rajan B; Ostrowski ML; Ramzy I; Schwartz MR
    Arch Pathol Lab Med; 1997 Feb; 121(2):134-8. PubMed ID: 9126040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular evidence for the expression of nicotinic acetylcholine receptor alpha-chain in mouse thymus.
    Wheatley LM; Urso D; Tumas K; Maltzman J; Loh E; Levinson AI
    J Immunol; 1992 May; 148(10):3105-9. PubMed ID: 1578136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in the research on immunopathogenesis of myasthenia gravis].
    Zieliński M; Kuzdzał J; Soja J; Szlubowski A
    Neurol Neurochir Pol; 2003; 37(5):1085-94. PubMed ID: 15174254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunizing mechanisms in thymoma and thymus.
    Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A
    Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.